Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians

This publication has 16 references indexed in Scilit:

• GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high‐risk population
  International Journal of Cancer, 2004
• Tobacco Smoke Carcinogens and Lung Cancer
  JNCI Journal of the National Cancer Institute, 1999
• Arylaminc N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese
  Pharmacogenetics, 1999
• Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
  Pharmacogenetics, 1998
• Identification of a Novel Allele at the HumanNAT1Acetyltransferase Locus
  Biochemical and Biophysical Research Communications, 1997
• The association of bladder cancer risk with ethnicity, gender, and smoking
  Annals of Epidemiology, 1993
• SHORT COMMUNICATION: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans
  Carcinogenesis: Integrative Cancer Research, 1993
• Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
  Carcinogenesis: Integrative Cancer Research, 1993
• Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants
  Pharmacogenetics, 1992
• Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression
  DNA and Cell Biology, 1990